Article
Use of a membrane potential-sensitive probe to assess biological expression of the cystic fibrosis transmembrane conductance regulator.
Human gene therapy - 1 Oct 1995
Renier M, Tamanini A, Nicolis E, Rolfini R, Imler J L, Pavirani A, Cabrini G
Abstract excerpt
Cystic fibrosis is caused by defects in a chloride-transporting protein termed cystic fibrosis transmembrane conductance regulator (CFTR). This study presents an innovative procedure to evaluate expression of functional CFTR. The technique uses the potential-sensitive probe bis-(1,3-diethylthiobarbituric acid) trimethine oxonol or DiSBAC2(3), by single-cell fluorescence imaging. The DiSBAC2(3) method was first...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
